198 related articles for article (PubMed ID: 17289216)
1. Structure-activity study on the LH- and FSH-releasing and anticancer effects of gonadotropin-releasing hormone (GnRH)-III analogs.
Kovács M; Vincze B; Horváth JE; Seprodi J
Peptides; 2007 Apr; 28(4):821-9. PubMed ID: 17289216
[TBL] [Abstract][Full Text] [Related]
2. Lamprey gonadotropin hormone-releasing hormone-III has no selective follicle-stimulating hormone-releasing effect in rats.
Kovacs M; Seprodi J; Koppan M; Horvath JE; Vincze B; Teplan I; Flerko B
J Neuroendocrinol; 2002 Aug; 14(8):647-55. PubMed ID: 12153467
[TBL] [Abstract][Full Text] [Related]
3. Lamprey GnRH-III stimulates FSH secretion in barrows.
Kauffold J; Schneider F; Zaremba W; Brüssow KP
Reprod Domest Anim; 2005 Oct; 40(5):475-9. PubMed ID: 16149955
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies of lGnRH-III through rational amino acid substitution and NMR conformational studies.
Pappa EV; Zompra AA; Diamantopoulou Z; Spyranti Z; Pairas G; Lamari FN; Katsoris P; Spyroulias GA; Cordopatis P
Biopolymers; 2012; 98(6):525-34. PubMed ID: 23203758
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationships.
Mezö I; Lovas S; Pályi I; Vincze B; Kálnay A; Turi G; Vadász Z; Seprödi J; Idei M; Tóth G; Gulyás E; Otvös F; Mák M; Horváth JE; Teplán I; Murphy RF
J Med Chem; 1997 Oct; 40(21):3353-8. PubMed ID: 9341910
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the ability of the three endogenous GnRHs to stimulate release of follicle-stimulating hormone and luteinizing hormone in chickens.
Proudman JA; Scanes CG; Johannsen SA; Berghman LR; Camp MJ
Domest Anim Endocrinol; 2006 Aug; 31(2):141-53. PubMed ID: 16300920
[TBL] [Abstract][Full Text] [Related]
7. Control of gonadotropin secretion by follicle-stimulating hormone-releasing factor, luteinizing hormone-releasing hormone, and leptin.
McCann SM; Karanth S; Mastronardi CA; Dees WL; Childs G; Miller B; Sower S; Yu WH
Arch Med Res; 2001; 32(6):476-85. PubMed ID: 11750723
[TBL] [Abstract][Full Text] [Related]
8. Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives.
Mezo G; Czajlik A; Manea M; Jakab A; Farkas V; Majer Z; Vass E; Bodor A; Kapuvári B; Boldizsár M; Vincze B; Csuka O; Kovács M; Przybylski M; Perczel A; Hudecz F
Peptides; 2007 Apr; 28(4):806-20. PubMed ID: 17254668
[TBL] [Abstract][Full Text] [Related]
9. Lamprey GnRH-III acts on its putative receptor via nitric oxide to release follicle-stimulating hormone specifically.
Yu WH; Karanth S; Mastronardi CA; Sealfon S; Dean C; Dees WL; McCann SM
Exp Biol Med (Maywood); 2002 Oct; 227(9):786-93. PubMed ID: 12324658
[TBL] [Abstract][Full Text] [Related]
10. Influence of synthetic lamprey GnRH-III on gonadotropin release and steroid hormone levels in gilts.
Brüssow KP; Schneider F; Tuchscherer A; Kanitz W
Theriogenology; 2010 Dec; 74(9):1570-8. PubMed ID: 20708243
[TBL] [Abstract][Full Text] [Related]
11. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".
Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J
Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313
[TBL] [Abstract][Full Text] [Related]
12. Is lGnRH-III the most potent GnRH analog containing only natural amino acids that specifically inhibits the growth of human breast cancer cells?
Herédi-Szabó K; Murphy RF; Lovas S
J Pept Sci; 2006 Nov; 12(11):714-20. PubMed ID: 16967433
[TBL] [Abstract][Full Text] [Related]
13. Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates.
Hegedüs R; Manea M; Orbán E; Szabó I; Kiss E; Sipos E; Halmos G; Mező G
Eur J Med Chem; 2012 Oct; 56():155-65. PubMed ID: 22967796
[TBL] [Abstract][Full Text] [Related]
14. lGnRH-III -- a promising candidate for anticancer drug development.
Manea M; Mező G
Protein Pept Lett; 2013 Apr; 20(4):439-49. PubMed ID: 23016589
[TBL] [Abstract][Full Text] [Related]
15. Evidence that gonadotropin-releasing hormone (GnRH) II stimulates luteinizing hormone and follicle-stimulating hormone secretion from monkey pituitary cultures by activating the GnRH I receptor.
Okada Y; Murota-Kawano A; Kakar SS; Winters SJ
Biol Reprod; 2003 Oct; 69(4):1356-61. PubMed ID: 12801988
[TBL] [Abstract][Full Text] [Related]
16. Role, mechanism of action and application of gonadoliberins in reproductive processes.
Teplán I
Acta Biol Hung; 1989; 40(1-2):3-36. PubMed ID: 2561244
[TBL] [Abstract][Full Text] [Related]
17. Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor.
Montagnani Marelli M; Manea M; Moretti RM; Marzagalli M; Limonta P
Int J Oncol; 2015 Jan; 46(1):243-53. PubMed ID: 25351635
[TBL] [Abstract][Full Text] [Related]
18. Lamprey GnRH-III releases luteinizing hormone but not follicle stimulating hormone in pigs.
Barretero-Hernandez R; Vizcarra JA; Bowen A; Galyean M
Reprod Domest Anim; 2010 Dec; 45(6):983-7. PubMed ID: 19497025
[TBL] [Abstract][Full Text] [Related]
19. Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties.
Janáky T; Juhász A; Rékási Z; Serfözö P; Pinski J; Bokser L; Srkalovic G; Milovanovic S; Redding TW; Halmos G
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10203-7. PubMed ID: 1332035
[TBL] [Abstract][Full Text] [Related]
20. Importance of the central region of lamprey gonadotropin-releasing hormone III in the inhibition of breast cancer cell growth.
Herédi-Szabó K; Lubke J; Toth G; Murphy RF; Lovas S
Peptides; 2005 Mar; 26(3):419-22. PubMed ID: 15652648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
